Skip to main content
Erschienen in:

25.01.2022 | Molecular Imaging

Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma

verfasst von: Mingxiao Li, Xiaohui Ren, Xuzhu Chen, Jincheng Wang, Shaoping Shen, Haihui Jiang, Chuanwei Yang, Xuzhe Zhao, Qinghui Zhu, Yong Cui, Song Lin

Erschienen in: European Radiology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Even very small residual tumors of IDH mutant 1p/19q non-codeleted (IDHmut-Noncodel) astrocytoma could have a significantly negative impact on survival; thus, accurate preoperative diagnosis is of utmost importance to guide aggressive tumor resection strategy for this subtype. This study aimed to diagnose IDHmut-Noncodel from IDH mutant 1p/19q codeleted (IDHmut-Codel) and IDH wild-type gliomas by preoperative MRI and CT to guide surgical plan-making.

Methods

Consecutive adult patients diagnosed with diffuse lower-grade glioma (LGG, histological grade 2–3) from December 1, 2013 to December 31, 2020, were retrospectively included in this study. Clinical and radiological features were recorded and analyzed. Patients were divided into cohort A and cohort B for training and validation based on the operation date (2:1).

Results

A total of 585 patients were included in this study (cohort A, 390; cohort B, 195). The hyperintense FLAIR rim with hypointense core (hyperFLAIRrim) was a more sensitive sign than T2-FLAIR mismatch (T2FM) in defining IDHmut-Noncodel astrocytoma (sensitivity in cohort A: 0.713, 0.539, respectively; in cohort B: 0.713, 0.489, respectively) without compromised specificity (all 1.00). The hyperFLAIRrim, higher rADC, homogenous pattern on T2WI, non-calcification, and younger age were the most important factors associated with IDHmut-Noncodel astrocytoma. Combining these factors, the random forest model showed the best predictive ability.

Conclusion

The hyperFLAIRrim sign was a specific and more sensitive sign in diagnosing IDHmut-Noncodel astrocytoma. Combining hyperFLAIRrim, higher rADC, homogenous pattern, non-calcification, and younger age could precisely predict glioma subtype for subsequent surgical plan-making.

Key Points

A single hyperintense FLAIR rim (hyperFLAIRrim) sign with a hypointense core, regardless of T2 appearance, was more sensitive than T2FM in diagnosing IDHmut-Noncodel astrocytoma with high specificity.
The higher rADC value, homogenous pattern on T2WI, non-calcification, and younger age have a close relationship with IDHmut-Noncodel astrocytoma.
Neurosurgeons should perform a more aggressive resection strategy to prolong survival for radiologically indicated IDHmut-Noncodel astrocytoma. Our study provided a usable, practicable, and reliable protocol for neurosurgeons to make an individualized surgical strategy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRef Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRef
2.
Zurück zum Zitat Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251CrossRef Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251CrossRef
5.
Zurück zum Zitat Patel SH, Bansal AG, Young EB et al (2019) Extent of surgical resection in lower-grade gliomas: differential impact based on molecular subtype. AJNR Am J Neuroradiol 40:1149–1155CrossRef Patel SH, Bansal AG, Young EB et al (2019) Extent of surgical resection in lower-grade gliomas: differential impact based on molecular subtype. AJNR Am J Neuroradiol 40:1149–1155CrossRef
6.
Zurück zum Zitat Wijnenga MMJ, French PJ, Dubbink HJ et al (2018) The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro Oncol 20:103–112CrossRef Wijnenga MMJ, French PJ, Dubbink HJ et al (2018) The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro Oncol 20:103–112CrossRef
7.
Zurück zum Zitat Jiang H, Cui Y, Liu X, Ren X, Li M, Lin S (2019) Proliferation-dominant high-grade astrocytoma: survival benefit associated with extensive resection of FLAIR abnormality region. J Neurosurg 132:998–1005CrossRef Jiang H, Cui Y, Liu X, Ren X, Li M, Lin S (2019) Proliferation-dominant high-grade astrocytoma: survival benefit associated with extensive resection of FLAIR abnormality region. J Neurosurg 132:998–1005CrossRef
8.
Zurück zum Zitat Rossi M, Gay L, Ambrogi F et al (2021) Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas. Neuro Oncol 23:812–826CrossRef Rossi M, Gay L, Ambrogi F et al (2021) Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas. Neuro Oncol 23:812–826CrossRef
9.
Zurück zum Zitat Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project. Clin Cancer Res 23:6078–6085CrossRef Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project. Clin Cancer Res 23:6078–6085CrossRef
10.
Zurück zum Zitat Throckmorton P, Graber JJ (2020) T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: variability and evolution. Neurology 95:e1582–e1589CrossRef Throckmorton P, Graber JJ (2020) T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: variability and evolution. Neurology 95:e1582–e1589CrossRef
11.
Zurück zum Zitat Li M, Ren X, Jiang H et al (2019) Supratentorial high-grade astrocytoma with leptomeningeal spread to the fourth ventricle: a lethal dissemination with dismal prognosis. J Neurooncol 142:253–261CrossRef Li M, Ren X, Jiang H et al (2019) Supratentorial high-grade astrocytoma with leptomeningeal spread to the fourth ventricle: a lethal dissemination with dismal prognosis. J Neurooncol 142:253–261CrossRef
13.
Zurück zum Zitat Li M, Dong G, Zhang W et al (2021) Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma. Cancer Sci 112:3699–3710CrossRef Li M, Dong G, Zhang W et al (2021) Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma. Cancer Sci 112:3699–3710CrossRef
14.
Zurück zum Zitat Yushkevich P, Piven J, Hazlett H et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116–1128CrossRef Yushkevich P, Piven J, Hazlett H et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116–1128CrossRef
15.
Zurück zum Zitat Xiong J, Tan W, Wen J et al (2016) Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours. Eur Radiol 26:1705–1715CrossRef Xiong J, Tan W, Wen J et al (2016) Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours. Eur Radiol 26:1705–1715CrossRef
16.
Zurück zum Zitat Tan WL, Huang WY, Yin B, Xiong J, Wu JS, Geng DY (2014) Can diffusion tensor imaging noninvasively detect IDH1 gene mutations in astrogliomas? A retrospective study of 112 cases. AJNR Am J Neuroradiol 35:920–927CrossRef Tan WL, Huang WY, Yin B, Xiong J, Wu JS, Geng DY (2014) Can diffusion tensor imaging noninvasively detect IDH1 gene mutations in astrogliomas? A retrospective study of 112 cases. AJNR Am J Neuroradiol 35:920–927CrossRef
17.
Zurück zum Zitat Kawaguchi T, Sonoda Y, Shibahara I et al (2016) Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. J Neurooncol 129:505–514CrossRef Kawaguchi T, Sonoda Y, Shibahara I et al (2016) Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. J Neurooncol 129:505–514CrossRef
18.
Zurück zum Zitat Garton ALA, Kinslow CJ, Rae AI et al (2020) Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas. J Neurosurg 134:1357–1367CrossRef Garton ALA, Kinslow CJ, Rae AI et al (2020) Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas. J Neurosurg 134:1357–1367CrossRef
19.
Zurück zum Zitat Ding X, Wang Z, Chen D et al (2018) The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study. J Neurooncol 140:591–603CrossRef Ding X, Wang Z, Chen D et al (2018) The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study. J Neurooncol 140:591–603CrossRef
20.
Zurück zum Zitat Lasocki A, Gaillard F, Gorelik A, Gonzales M (2018) MRI features can predict 1p/19q status in intracranial gliomas. AJNR Am J Neuroradiol 39:687–692CrossRef Lasocki A, Gaillard F, Gorelik A, Gonzales M (2018) MRI features can predict 1p/19q status in intracranial gliomas. AJNR Am J Neuroradiol 39:687–692CrossRef
22.
Zurück zum Zitat Broen MPG, Smits M, Wijnenga MMJ et al (2018) The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study. Neuro Oncol 20:1393–1399CrossRef Broen MPG, Smits M, Wijnenga MMJ et al (2018) The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study. Neuro Oncol 20:1393–1399CrossRef
23.
Zurück zum Zitat Batchala PP, Muttikkal TJE, Donahue JH et al (2019) Neuroimaging-based classification algorithm for predicting 1p/19q-codeletion status in IDH-mutant lower grade gliomas. AJNR Am J Neuroradiol 40:426–432PubMedPubMedCentral Batchala PP, Muttikkal TJE, Donahue JH et al (2019) Neuroimaging-based classification algorithm for predicting 1p/19q-codeletion status in IDH-mutant lower grade gliomas. AJNR Am J Neuroradiol 40:426–432PubMedPubMedCentral
24.
Zurück zum Zitat Aliotta E, Dutta SW, Feng X et al (2020) Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign. J Neurooncol 149:325–335CrossRef Aliotta E, Dutta SW, Feng X et al (2020) Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign. J Neurooncol 149:325–335CrossRef
25.
Zurück zum Zitat Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS (2020) Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Eur Radiol 30:844–854CrossRef Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS (2020) Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Eur Radiol 30:844–854CrossRef
28.
Zurück zum Zitat Juratli TA, Tummala SS, Riedl A et al (2019) Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups. J Neurooncol 141:327–335CrossRef Juratli TA, Tummala SS, Riedl A et al (2019) Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups. J Neurooncol 141:327–335CrossRef
31.
Zurück zum Zitat Surov A, Meyer H, Wienke A (2017) Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget 8:59492–59499CrossRef Surov A, Meyer H, Wienke A (2017) Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget 8:59492–59499CrossRef
32.
Zurück zum Zitat Surov A, Meyer HJ, Wienke A (2017) Correlation between minimum apparent diffusion coefficient (ADCmin) and tumor cellularity: a meta-analysis. Anticancer Res 37:3807–3810PubMed Surov A, Meyer HJ, Wienke A (2017) Correlation between minimum apparent diffusion coefficient (ADCmin) and tumor cellularity: a meta-analysis. Anticancer Res 37:3807–3810PubMed
33.
Zurück zum Zitat Jenkinson MD, Smith TS, Brodbelt AR, Joyce KA, Warnke PC, Walker C (2007) Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 26:1405–1412CrossRef Jenkinson MD, Smith TS, Brodbelt AR, Joyce KA, Warnke PC, Walker C (2007) Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 26:1405–1412CrossRef
34.
Zurück zum Zitat Kim M, Jung SY, Park JE et al (2020) Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Eur Radiol 30:2142–2151CrossRef Kim M, Jung SY, Park JE et al (2020) Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Eur Radiol 30:2142–2151CrossRef
35.
Zurück zum Zitat Aliotta E, Nourzadeh H, Batchala PP et al (2019) Molecular subtype classification in lower-grade glioma with accelerated DTI. AJNR Am J Neuroradiol 40:1458–1463PubMedPubMedCentral Aliotta E, Nourzadeh H, Batchala PP et al (2019) Molecular subtype classification in lower-grade glioma with accelerated DTI. AJNR Am J Neuroradiol 40:1458–1463PubMedPubMedCentral
36.
Zurück zum Zitat Wu CC, Jain R, Radmanesh A et al (2018) Predicting genotype and survival in glioma using standard clinical MR imaging apparent diffusion coefficient images: a pilot study from The Cancer Genome Atlas. AJNR Am J Neuroradiol 39:1814–1820CrossRef Wu CC, Jain R, Radmanesh A et al (2018) Predicting genotype and survival in glioma using standard clinical MR imaging apparent diffusion coefficient images: a pilot study from The Cancer Genome Atlas. AJNR Am J Neuroradiol 39:1814–1820CrossRef
37.
Zurück zum Zitat Thust SC, Hassanein S, Bisdas S et al (2018) Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis. Eur Radiol 28:3779–3788CrossRef Thust SC, Hassanein S, Bisdas S et al (2018) Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis. Eur Radiol 28:3779–3788CrossRef
38.
Zurück zum Zitat Xing Z, Yang X, She D, Lin Y, Zhang Y, Cao D (2017) Noninvasive assessment of IDH mutational status in World Health Organization grade II and III astrocytomas using DWI and DSC-PWI combined with conventional MR imaging. AJNR Am J Neuroradiol 38:1138–1144CrossRef Xing Z, Yang X, She D, Lin Y, Zhang Y, Cao D (2017) Noninvasive assessment of IDH mutational status in World Health Organization grade II and III astrocytomas using DWI and DSC-PWI combined with conventional MR imaging. AJNR Am J Neuroradiol 38:1138–1144CrossRef
40.
Zurück zum Zitat Saito T, Muragaki Y, Maruyama T et al (2016) Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas. Brain Tumor Pathol 33:175–182CrossRef Saito T, Muragaki Y, Maruyama T et al (2016) Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas. Brain Tumor Pathol 33:175–182CrossRef
41.
Zurück zum Zitat Kiroglu Y, Calli C, Karabulut N, Oncel C (2010) Intracranial calcifications on CT. Diagn Interv Radiol 16:263–269PubMed Kiroglu Y, Calli C, Karabulut N, Oncel C (2010) Intracranial calcifications on CT. Diagn Interv Radiol 16:263–269PubMed
42.
Zurück zum Zitat Bitton RR, Pauly KR (2014) MR-acoustic radiation force imaging (MR-ARFI) and susceptibility weighted imaging (SWI) to visualize calcifications in ex vivo swine brain. J Magn Reson Imaging 39:1294–1300CrossRef Bitton RR, Pauly KR (2014) MR-acoustic radiation force imaging (MR-ARFI) and susceptibility weighted imaging (SWI) to visualize calcifications in ex vivo swine brain. J Magn Reson Imaging 39:1294–1300CrossRef
43.
Zurück zum Zitat Saade C, Najem E, Asmar K, Salman R, El Achkar B, Naffaa L (2019) Intracranial calcifications on CT: an updated review. J Radiol Case Rep 13:1–18PubMedPubMedCentral Saade C, Najem E, Asmar K, Salman R, El Achkar B, Naffaa L (2019) Intracranial calcifications on CT: an updated review. J Radiol Case Rep 13:1–18PubMedPubMedCentral
45.
Zurück zum Zitat Zhao K, Sun G, Wang Q et al (2021) The diagnostic value of conventional MRI and CT features in the identification of the IDH1-mutant and 1p/19q co-deletion in WHO grade II gliomas. Acad Radiol 28:e189–e198CrossRef Zhao K, Sun G, Wang Q et al (2021) The diagnostic value of conventional MRI and CT features in the identification of the IDH1-mutant and 1p/19q co-deletion in WHO grade II gliomas. Acad Radiol 28:e189–e198CrossRef
46.
Zurück zum Zitat Waitkus MS, Diplas BH, Yan H (2018) Biological role and therapeutic potential of IDH mutations in cancer. Cancer Cell 34:186–195CrossRef Waitkus MS, Diplas BH, Yan H (2018) Biological role and therapeutic potential of IDH mutations in cancer. Cancer Cell 34:186–195CrossRef
47.
Zurück zum Zitat Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ (2019) Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis. Eur Radiol 29:745–758CrossRef Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ (2019) Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis. Eur Radiol 29:745–758CrossRef
48.
Zurück zum Zitat Xu H, Xia YK, Li CJ et al (2019) Rapid diagnosis of IDH1-mutated gliomas by 2-HG detection with gas chromatography mass spectrometry. Lab Invest 99:588–598CrossRef Xu H, Xia YK, Li CJ et al (2019) Rapid diagnosis of IDH1-mutated gliomas by 2-HG detection with gas chromatography mass spectrometry. Lab Invest 99:588–598CrossRef
Metadaten
Titel
Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma
verfasst von
Mingxiao Li
Xiaohui Ren
Xuzhu Chen
Jincheng Wang
Shaoping Shen
Haihui Jiang
Chuanwei Yang
Xuzhe Zhao
Qinghui Zhu
Yong Cui
Song Lin
Publikationsdatum
25.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 6/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-021-08500-w

Neu im Fachgebiet Radiologie

Hölzerner Fremdkörper in der Orbita? Zuerst eine CT!

Besteht der Verdacht, dass ein Fremdkörper aus Holz in den Orbitalraum eingedrungen ist, spielt die Bildgebung eine entscheidende diagnostische Rolle. Was von CT und MRT zu erwarten ist, hat ein chinesisches Radiologenteam untersucht.

Diagnostik von Rippenfrakturen: KI schlägt Radiologen

Mensch gegen Maschine: Beim Erkennen von Rippenfrakturen in Röntgen- und CT-Aufnahmen entschied sich dieses Duell zugunsten der künstlichen Intelligenz (KI). Die Algorithmen zeigten eine höhere Sensitivität als ihre menschlichen Kollegen.

Ärztinnen überholen Ärzte bei Praxisgründungen

Bei Praxisgründungen haben inzwischen die Frauen deutlich die Nase vorn: Seit zehn Jahren wagen laut apoBank mehr Ärztinnen als Ärzte den Schritt in die Selbstständigkeit. In puncto Finanzierung sind sie aber vorsichtiger als die männlichen Kollegen.

Ambulante Behandlung darf länger dauern als stationäre

Ambulante Behandlungen haben Vorrang vor stationären - auch wenn diese läner dauern. Das hat das Bundessozialgericht klargestellt. Konkret ging es um Liposuktionen der Ober- und Unterschenkel.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.